Gland Pharma Limited (NSE: GLAND) reported Revenue from Operations of ₹938.28 Crore down from ₹1,063.32 Crore year on year, a decline of 11.8%. Consolidated Net Profit of ₹231.94 Crore, slumped 15% from ₹273 Crore in the same quarter of the previous year. The Earnings per Share is ₹14.08 for this quarter.
Gland Pharma Limited Q3 FY23; Net Profit Down To 232 Crore
Related Post
- Garden Reach Shipbuilders & Engineers Ltd Q2FY25; 10% rise in Profits
Garden Reach Shipbuilders & Engineers Ltd is a premier shipbuilding company in India under the…
-
GAIL (India) Ltd Q2FY25; 10% rise in Profits
Incorporated in 1984, GAIL, a Government of India undertaking, is an integrated natural gas company…
-
G R Infraprojects Ltd Q2FY25; 11% fall in Profits
Incorporated in the year 1995, G R Infraprojects Ltd is an integrated road Engineering, Procurement,…